Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
... promising Phase 2 picoplatin data from our colorectal
and prostate cancer programs. These data further ... by the end of this year.
Cancer (CRC) : Presented new progression-free ... cell lung cancer and Phase 2 trials in metastatic colorectal
and castration-resistant (hormone refractory) ...
Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients
... effectiveness of cetuximab (ERBITUX(R)) on the colorectal
cancer cells of individual patients. Results from the study show that of the 54 primary colorectal
cultures tested, eight percent were responsive to ... reported clinical response rate for cetuximab in colorectal
carcinoma patients (11 percent). A predictive ...
Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology
... KRX-0401 in Advanced Renal Cell Carcinoma, colorectal
Cancer and Gastrointestinal Stromal Tumors (GIST) ... of patients with advanced renal cell carcinoma, colorectal
cancer and GIST.
Abstracts selected for ... 2:00pm - 6:00pm (Level 2, West Hall C)
Sunday, May 31 st , 2009: ...
Beyond associations: Colorectal cancer culprit found
... Genetics plays a key role in determining risk for colorectal
cancer, the second leading cause of ... genetic variation associated with the risk of colorectal
cancer and its functional implications, shedding ... down the genes that underlie diseases such as colorectal
cancer is extremely difficult, owing to the ...
Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Research's 100th Annual Meeting
... -- Phase 1 Data from colorectal
Cancer and Oral Picoplatin Trials To Be Presented ... data from its Phase 1 trial of picoplatin in colorectal
cancer (CRC) and bioavailability data from its ... 5-fluorouracil and
leucovorin (FOLPI) for colorectal
cancer (CRC): Comparison of two
ScreenCancer Adds InSure(R) FIT(TM) Colorectal Cancer Screening Test to European Cancer Screening Program
... it has added the InSure(R)
FIT(TM) take-at-home colorectal
cancer screening test to its European ... risk.
"We are pleased to provide annual colorectal
cancer screening with InSure
FIT to our ... shown to be highly effective in helping to detect colorectal
earlier, and, we believe, is the easiest ...
Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon
... device and its potential for saving lives."
cancer is the second leading cause of cancer ... of people have a colonoscopy to screen for colorectal
Colonoscopy is widely regarded as ... more than 10,000 cancer patients who died of colorectal
cancer indicated that colonoscopy missed about ...
Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers
... clinically studied in gastric, pancreatic, and colorectal
cancers. Cato Research Ltd. (Cato Research) will ... with PAS to date for gastric, pancreatic, and colorectal
cancers. Cancer Advances will be seeking ... trials including gastric, pancreatic, and colorectal
cancer and is cleared for development in 17 North ...
Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
... Alternative to Oxaliplatin in First-Line colorectal
Cancer Treatment -
SOUTH SAN FRANCISCO, ... trial of picoplatin in patients with metastatic colorectal
cancer (CRC). Results continue to suggest that ... that picoplatin is an active platinum agent in colorectal
cancer, but without the significant neuropathy ...
First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer
... NKTR-102 versus irinotecan in
cancer patients with the KRAS gene mutation, and ... studies in breast, ovarian, cervical and colorectal
cancers, a Phase
2a study evaluating NKTR-102 in ... monotherapy. It
is estimated that up to 45% of colorectal
cancer cases have this mutation in
the KRAS gene ...
Oncology Biomarker KRAS to be Discussed at FDA Panel Meeting
... KRAS Biomarker PresentsPotential toPersonalize colorectal
Cancer Treatment Determining Who Can Benefit from ... predictive biomarker in patients with metastatic colorectal
cancer (mCRC) treated with anti-epidermal growth ... the KRAS gene in guiding treatment of advanced colorectal
In November, the ...
New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
... simulation of the laparoscopic colorectal
Although minimally invasive ... without potentially putting patients at risk. colorectal
the most common treatment for colorectal
cancer, which accounts for almost
10% of all ...
GeneNews appoints Canadian Colorectal Cancer Advisory Board
... today announced the formation of a Canadian colorectal
Cancer Advisory Board. Drs. Lawrence Cohen, ... test to determine a person's current risk for colorectal
"Following our July launch of ... education sessions on the need to engage in colorectal
cancer screening and how increased compliance can ...
InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
... DXL1218 (EGFR), for the prospective
treatment of colorectal
"Recent experimental data suggests that ... and applicable securities legislation.
cancer is the third most common cancer found in ...
Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
... trial of picoplatin in patients
with metastatic colorectal
cancer (CRC). The expanded and updated ... "Picoplatin appears to be an active platinum in colorectal
without the neurotoxicity of the other ... "These interim, proof-of-concept Phase 2 colorectal
results are encouraging and continue ...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
... agent and with
chemotherapy for certain types of colorectal
cancers and as a single agent
or in combination ... new indications in first-line head
and neck, colorectal
and non-small cell lung cancer. Given that three ... whom prior platinum-based therapy has failed.
ERBITUX, as a single agent, is indicated ...
GeneNews Announces Second Quarter Results
... to assess a patient's current risk of having colorectal
the completion of our Company's ... resulting in improved outcomes for
patients with colorectal
cancer," said Dr. Heiner Dreismann, Lead ... launched the world's first blood test for colorectal
cancer screening in the Greater Toronto Area.
Genzyme Reports Strong Second-Quarter Growth
... to expand the
product's use in gynecologic and colorectal
surgery and C-section
... demand for its KRAS mutation
testing for colorectal
cancer, as recent studies have shown ... in selecting treatment
for patients with colorectal
cancer. This increasing recognition of the
GeneNews launches world's first blood test for colorectal cancer screening
... the world's first blood-based molecular test
cancer screening. ColonSentry(TM) is a blood test that
assesses a patient's current risk of having colorectal
those in the asymptomatic ... which could increase the detection rate of colorectal
as much as 3 fold in an asymptomatic ...
Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
... annual colorectal
cancer screening test. Although colorectal
cancer is the second leading
cause of cancer in ... FIT was found to
have 33% greater sensitivity for colorectal
cancer than a leading
guaiac-based FOBT screening ... number of
people getting screened annually for colorectal
cancer -- and the launch of
InSure Quik F I T, ...
Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
... enrollment in our Phase 2 trial in
cancer. The results of our Phase 1 trials in prostate
cancer and colorectal
cancer were presented earlier this year. ... Phase 3 data is targeted for mid-2009.
Cancer: In January, we presented preliminary ...
GeneNews Announces First Quarter Results
... a risk stratification test for colorectal
Dr. K. Wayne Marshall, President ... Greater Toronto Area who should be
screened for colorectal
cancer, the vast majority of whom do not ... from a validation study of a panel of six colorectal
cancer biomarkers, confirming (p the panel ...
GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
... to stratify a population with average risk for colorectal
- Increased ... 3-fold increased probability of currently having colorectal
cancer. - Average Probability: 20% were defined ... an average probability of currently having colorectal
cancer. - Decreased Probability: 62% were ...
Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
... 31% of patients (n=1,818) completed
an at-home colorectal
screening test.(3) Sadly, despite the ... men and
women in the U.S. will be diagnosed with colorectal
cancer this year, and
one third of these patients ... is 90%(5), yet less than 40 percent of colorectal
cancers are found
"We are launching ...
GeneNews announces 2007 year end results
... Five-Gene Biomarker Set for the Detection of colorectal
Cancer" in the Clinical Cancer Research journal. ... that an abstract entitled "Stratification of colorectal
cancer probability using six genes from ... diagnostic test kits for use in the management of colorectal
disease in a laboratory setting. - ...
GeneNews selected to present late-breaking abstract at AACR Annual Meeting
... of current risk for colorectal
TORONTO, March 17 ... for the assessment of
a person's current risk for colorectal
cancer from a blood sample, has been
selected for ... abstract is entitled "Stratification of colorectal
using six genes from whole ...
Colon Cancer Screening Laws Now Cover Half of U.S. Population
... of states receiving an "A"
grade on the 2008 colorectal
Cancer Legislation Report Card. Despite ... who needs it."
Commonly known as colon cancer, colorectal
cancer is the second leading
cause of cancer ... recommends that
average-risk adults should begin colorectal
cancer screening at age 50
years with one of ...
Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer
... laboratory test that can help physicians
cancer based on a patient's blood specimen. ... the Septin 9 gene is a marker in blood plasma of colorectal
second leading cause of ... simple blood test that can detect a biomarker
cancer will be a significant advance in the fight ...
AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
monitoring patients previously diagnosed with colorectal
cancer. AMDL used
the guidance provided at the ... DR-70(R) (FDP) ELISA is effective at
cancer patients. AMDL's DR-70(R) (FDP) ELISA is ... patients who
have been previously diagnosed with colorectal
cancer. AMDL believes that
the test will be ...
Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
... changes which
lead to the development of colorectal
cancer. In addition to the SAB appointment, OGeS ... cancer drug development
candidates in the area of colorectal
cancer. Prior to taking up his current position, ... a new
diagnostic protein panel for relapsing colorectal
cancer. In parallel, OGeS
provides biomarker ...
Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
... imaging diagnostics
for Crohn's disease (CD) and colorectal
cancer. The BMP consortium was
approved for three ... disease
and a great opportunity for diagnosing colorectal
cancer," stated Dr.
Elisha Rabinovitz, the head ... and
first-in-class screening tests for breast and colorectal
cancers. For more information, please contact:
YM BIOSCIENCES REPORTS 2007 YEAR END OPERATIONAL AND FINANCIAL RESULTS
development in a number of trials, including colorectal
cancer, adult and
pediatric glioma, ... Japan. - YM initiated enrollment for a Phase II colorectal
cancer trial in Canada. The first 50-patient ... 20 patients were recruited into the Phase II colorectal
trial by the date of this release.
New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation
adjuvant stage III colon cancer and advanced colorectal
cancer, which is
expected to offer more ... of
cancer in some patients with advanced colorectal
cancer. "We developed the Eloxatin(R) 200 mg ... resulting in added cost savings." About colorectal
Cancer Strides have been made in the management ...
ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
... for the
initial treatment of metastatic colorectal
cancer. CoFactor is a
folate-based biomodulator ... of CoFactor for the treatment of metastatic colorectal
the U.S. and in Europe. Patients ... to receive regulatory approval
for metastatic colorectal
cancer or other indications on a timely basis ...
Sanofi-aventis Announces Second Quarter 2009 Results
Eloxatin ((R)) , the leading cytotoxic agent in the colorectal
cancer market as an adjuvant and as a first-line treatment in the ... sensory neuropathy induced by oxaliplatin in patients with metastatic colorectal
cancer did not attain its primary end point. It was therefore decided to ...
Healthy Advice Networks Announces Improved Patient Outcomes in Physicians' Offices with Healthy Advice Programs
... Healthy Advice educational segments highlight the importance of PSA and colorectal
Scott Nesbitt, Executive Vice President, Analytics and ... that screening saves lives. The American Cancer Society has identified colorectal
cancer as a major priority since there is such great potential to prevent ...
Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use
... for improving immunotherapeutic delivery strategies in metastatic colorectal
(CRC) and other forms of cancer.
The Cell Sense technology makes ... vaccines to treat CRC, directed by Drs. Kalinski and Bartlett.
CRC is the third leading cancer in the United States and the ...
Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
... a randomized phase 2 clinical trial with adecatumumab in patients with colorectal
cancer after complete resection of liver metastases.
"These data ... KGaA of Darmstadt, Germany. Adecatumumab is in a phase 2 clinical trial in colorectal
carcinoma patients after complete resection of liver metastases, and a ...
AEterna Zentaris to Present Data Supporting Evaluation of AEZS-108 in Prostate Cancer at Upcoming ASCO Meeting
... agents, in the treatment of patients with advanced renal cell carcinoma, colorectal
cancer and GIST (gastrointestinal stromal tumors).
Abstracts selected ... Daniel Cho, MD
Poster Session: 2 pm - 6 pm (Level 2, West Hall C)
Sunday, May 31, 2009
#4081: Randomized Phase 2 study of ...
Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
... in small cell lung cancer and the upcoming proof-of-concept data in the colorectal
and prostate cancers programs make the compound an attractive partnering ... a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal
and castration-resistant (hormone refractory) prostate cancers. The ...